| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |